Immix Biopharma | Investor Presentation Deck | 61 slides · page 47 of 61
Shows two parallel tracks: monotherapy and combination therapy with tislelizumab.
Pitch deck · roadmap · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 6/6
diagram 1/1 image 2/2 metric 2/2 title 1/1
Components 6
process logo logo big-number big-number headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1